Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Syzygium aromaticum extract, commonly known as clove extract, is a botanical extract derived from the dried flower buds of the clove plant. It is rich in bioactive phytocompounds, most notably eugenol, eugenyl acetate, and beta-caryophyllene. The extract has been extensively researched for its diverse pharmacological properties, including potent antioxidant, anti-inflammatory, and antimicrobial activities. Specifically, it has shown inhibitory effects against Helicobacter pylori and Candida species. In the context of metabolic health, the extract has been investigated for its ability to inhibit key carbohydrate-digesting enzymes, such as alpha-amylase and alpha-glucosidase, suggesting potential utility in managing hyperglycemia. Additionally, it has been explored for neuroprotective and anticancer effects in various preclinical models.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on syzygium aromaticum extract.